Omaha’s Power To End Stroke ambassadors are planning a free, hip-shaking fitness class on Nov. 5.
The Power-a-Thon is from 10 a.m. to noon at Omaha North High School Gym, 4410 N. 36th Street. All ages and fitness levels are welcome. No advance registration is required.
Power To End Stroke is the American Stroke Association’s education and awareness campaign that embraces and celebrates the culture, energy, creativity and lifestyles of African Americans to prevent and overcome stroke.
“If you’ve been wanting to try a group exercise classes like Zumba ® or just spice up your normal routine, this free event is for you,” said Theola Cooper, Omaha Power To End Stroke Ambassador. “It will be a great workout for both beginners and experts.”
Obesity, a modifiable risk factor for heart disease and stroke, is a serious threat in Douglas County and nationwide. Among Douglas County adults:
* 64% are obese or overweight
* 70% get less than 20 minutes of exercise three times a week
* 76% don’t eat five servings of fruits or vegetables each day
“Heart disease and stroke are major health concerns for all people, but African Americans are at particularly high risk,” said Wayne Houston, president of the Omaha Power To End Stroke Ambassador Council. “The Power Council is excited to bring this first-time event to North Omaha and give our community another tool to improve heart and brain health.”
According to the American Heart Association, a healthy diet and regular exercise are two of your best friends when it comes to health. The American Heart Association recommends at least 150 minutes per week of physical activity.
“Many people dread the thought of exercising, but on Saturday, Nov. 5, we’re going to show you how a trip to the gym is something to look forward to, not fear,” said Kechia Smith, Health Equity director for the American Heart Association. “You’ll be burning calories with a smile on our face.”
Omaha’s Power-a-Thon is sponsored in part by the Black Family Health & Wellness Association. Power To End Stroke is nationally sponsored by Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.